This is a past event. Registration is closed. View other FORTUNE China events.
More speakers of FORTUNE China 40 Under 40 EVENT will be announced soon, please stay tuned!
VICTOR AI
FOUNDER AND CEO, TERMINUS GROUPVictor AI is a forward-thinking entrepreneur and a dedicated advocate of future technology. He was awarded as Fortune’s ‘Top 40 under 40’ by Fortune Magazine in 2019 and 2022.
Victor is the founder and CEO of Terminus Group, a China-based leading AIOT service provider. Terminus Group aims to transform futuristic urban development and construct sustainable digital innovation ecosystem with AIOT technologies. Over the years, Terminus Group has managed to successfully secure its leading position in the industry, not only by being at the forefront of emerging technologies, but also by deploying its proven solutions in different cities around the globe.
Under Victor’s leadership, Terminus Group was announced as the only Official Premiere Partner of Expo 2020 Dubai from China in 2020. Terminus Group’s innovative technology has been featured in Gartner’s technology trending report six times. In 2021, Terminus AI CITY Operating System, a city-level operating system developed by the company was awarded by leading tech media Leiphone.com as the best independently-developed technology.
Victor has also had a distinguished career in the private equity industry. Over the past 10+ years, Victor has closed over 100 deals in private equity investment with an AUM exceeding USD 10B. He has closed a series of signature deals including amongst others, Meituan (3690.HK), iQiyi (NASDAQ:IQ), NIO (NYSE:NIO), SenseTime, Netease Cloud Music, Xpeng Motors, JD Logistics and China UnionPay, etc.
KERWIN CHEN
FOUNDER ANDCHAIRMAN, KOKA LIFESCIENCESKerwin Chen, has been engaged in the research of interventional therapy technology in the field of valvular heart disease for a long time. In 2018, He founded a technology company focusing on the research and development of cardiac valve interventional devices. The products under development are aimed at the field of valvular heart disease, closely following the development trend of interventional cardiology, and domestic innovations filling the gap in clinical needs.
Our team has accumulated rich experience in R&D and production in the field of interventional valve products, has built a technology platform with independent intellectual property rights, and has formed a comprehensive research and development layout of cardiology, cardiac surgery mitral valve repair product pipeline, a new generation of transfemoral vein balloon expansion aortic valve products, etc.. Currently, several products have entered into the clinical trial stage. Our products have differentiated characteristics and are expected to provide a variety of solutions for minimally invasive valve treatment for the majority of domestic clinicians and patients.
QIUFAN CHEN
SPECULATIVE FICTION AUTHORChen Qiufan (a.k.a. Stanley Chan) is an award-winning Chinese speculative fiction author, translator, creative producer, and curator. He is Vice president of Chinese Writers Association Science Fiction Committee, honorary president of the Chinese Science Fiction Writers Association, Culture Leader of World Economic Forum(2018/2019), Asia 21 Society Young Leader (2022), and has a seat on the Xprize Foundation Science Fiction Advisory Council. His works include the novel Waste Tide and, co-authored with Kai-Fu Lee, the book AI 2041: Ten Visions for Our Future. He currently lives in Chateau de Lavigny, Switzerland as writer-in-resident of Pro Helvetia.
ZHENWEI GUO
MANAGING DIRECTOR, SEQUOIA CHINAGuo Zhenwei, Managing Director of Sequoia China, who is responsible for investment in the consumer industry. The main projects include Winner Medical, Purcotton, Junlebao, Weilong, BEKE, Genki Forest, BABO, Urban Rivivo, Amer Sports, Buy Quickly，Dahiti, Ramen Talk, Simple Love, Jiang Xiaobai, JD.com, Meituan, etc. He used to be an analyst in the research department of China International Capital Corporation Limited and a senior auditor of Deloitte Touche Tohmatsu Certified Public Accountants. Mr. Guo Zhenwei holds a bachelor's degree from Central University of Finance and Economics and an EMBA degree from China Europe International Business School.
BICHENG HAN
FOUNDER AND CEO, BRAINCOBicheng Han is the founder and CEO of BrainCo. He is dedicated in the research and application using the technology of non-invasive brain-computer interface (BCI). Bicheng found BrainCo in 2015, while he was pursuing his PhD degree at Harvard Center for Brain Science. The company has now grown into a world-leading brain-computer interface (BCI) company and the first unicorn among all BCI companies in the world. Their technology has been applied in multiple fields to help people with different needs, from neurological diseases like ADHD, Alzheimers, and Autism, to prostheses that help people with disabilities regain control over their body. For his work in BCI, he was awarded the “MIT Tech Review China 35 Innovators under 35”. Their product was selected as “Best inventions of the year” by TIME magazine.
ISAAC JING
FOUNDER AND CEO, UMADr. Jing Yan, Graduated from University of Science and Technology of China, Founder and CEO of UMA Intelligent Group, and Head of Shaanxi Intelligent Robot Innovation Center. He was listed on 2022 Fortune China 40 Under 40、36Kr「X· 36Under36」、 Shaanxi Province "SanQin Scholars" innovation team.
He founded the UMA Intelligent Group in December 2019, with the mission of "Improving the working environment of 20 million welder around the world". At present, UMA has become the only intelligent solution provider in the world that applied intelligent welding decision-making technology to production. Because UMA redefines the welding, welders can monitor welding equipment at the software, which can help professional welding talents keep away from harsh environments.
DAVID LI
CO-FOUNDER AND CEO, HESAI TECHNOLOGYDr. David Li, Co-Founder and CEO of Hesai Technology, expert in robotics & motion control and leader in the global autonomous driving industry. David Li’s numerous accolades include being named as “2021 Young Global Leader”, “Fortune Magazine - Forty Under 40 in China”, “MIT Technology Review - 35 Innovators Under 35”, “Designer of ’Red Dot Award’ in Germany”.
David Li received his PhD in Robotics from the University of Illinois at Urbana-Champaign (USA), and his BS degree in Mechanical Engineering from Tsinghua University (China). Prior to founding Hesai, David Li served as a principal engineer at Western Digital in Silicon Valley. David Li has more than 100 patents in the fields of robotics, motion control, sensors and advanced manufacturing. His hobbies include marathons, basketball and photography.
JERRY LI
FOUNDER AND CEO, TUNGEEJerry Li ,the founder and CEO of Tungee.com, a serial entrepreneur, graduated from Sun Yat-Sen University. In 2015, he was rated Most Creative People inBusiness 100. In 2017, he was listed on Forbes China 30 Under 30 list. In the sameyear, he was listed on Hurun China Under 30s To Watch. In 2019, he was listed on Forbes Asia 30 Under 30 list. In 2022, he was listed on Fortune 40 Under 40.
Tungee is the pioneer of intelligent sales SaaS, dedicated to using big data and AI technology to help enterprises improve sales efficiency and performance comprehensively. Since its establishment, Tungee has maintained rapid development with consistent revenue growth. Headquartered in Guangzhou, Tungee has more than 20 branches and offices and over 1,500 employees across China.
At present, Tungee serves more than 10,000 customers,including Alibaba, Microsoft, Amazon, Dell and other industry giants. It has been awarded the title of " Specialized, Refinement, Differential, Innovation", and "High-Precision", "and has been ranked on "Unicorn" Innovative Enterprise List and Hurun Report's "Global Unicorn" list.
GONGRUN LIU
DEPUTY DIRECTOR, CEIBS LUJIAZUI INSTITUTE OF INTERNATIONAL FINANCEDr. Liu gongrun is currently deputy director and researcher of CEIBS Lujiazui Institute of international finance. He is a doctor and postdoctoral of Fudan University. He is also a special expert and deputy secretary-general of Shanghai payment Association, a member of Shanghai Xuhui District CPPCC, a member of financial trial theory special committee of China law society, and an expert of financial technology special committee of Shanghai Modern Service Industry Federation. His main research interests include political and economic operation, construction of international financial center and development of digital finance. He has published some books and published more than 100 articles in academic journals.
NICK NIE
PARTNER, China Creation Ventures (CCV)Nick Nie joined CCV since its establishment in 2017, and now he is the Partner focusing on early-stage of AI, Metaverse, digital twin solutions and startups with business overseas. Nick participated investments in the star portfolios like Wanka Online (01762.HK), Joyrun, Cishi Culture, G-HCare,Zixel Menya and Tikinmedia.
Before joining CCV, Nick has worked in KPCB China as the core TMT member, and participated in the investment of Tantan, based on his in-depth insights and mobile internet foresight. Nick also had some stint in Tencent and Accenture, which accumulated rich experience and understanding in mobile internet and enterprise strategy and operation. Nick also had successful firsthand entrepreneurial experience which would be a rare value for his VC career.
Nick holds a Bachelor’s degree in Economics from Renmin University of China.
PENG YAO
FOUNDER, CHAIRMAN AND CEO, SHANMA INTELLIGENT TECHNOLOGYPeng Yao, the founder, chairman and CEO of Shanghai ShanMa Intelligent Technology Co., Ltd., is a member of Jiu San Society and also a senior engineer. He assumes the vice president of the Second Council of Zhejiang Young Entrepreneurs’ Association, Shanghai and deputy director of the "Joint Innovation Center for urban space intelligent management", which is created by Shanghai Institute for Advanced Study of Zhejiang University and Supremind. Graduated from Zhejiang University, Peng Yao has more than ten years of experience in cloud computing, AI research and intelligent product innovation. He used to be the founder of Qiniu Limited Artificial Intelligence Laboratory, the technical partner of Qiniu Limited products, the deputy director of Fudan-Qiniu deep learning laboratory, the product R&D manager of IBM Global System Technology Laboratory and the expert representative of China Construction Bank head office. Since 2016, Peng Yao has continuously and successfully cultivated and expanded two industrial unicorn enterprises within 7 years. In April 2019, he founded Supremind. In respects of awards, Peng Yao has won “40 Chinese Business Elites under-40” of Fortune, 2021 Outstanding Innovation and Entrepreneurship Talents in Zhangjiang National Independent Innovation Demonstration Zone, 2021 Top 10 Chinese Entrepreneurs, etc.
SHAOLONG SUI
FOUNDER AND CEO, BUILDERXSui Shaolong, Serial Entrepreneur, graduated from Shanghai Jiaotong University, Michigan College and got a master's degree from Stanford University, who worked as a core engineer in Apple and Tesla. In 2017, Sui was presented in Forbes "30 Under 30 Asia" list. In 2020, he was awarded as the "Beijing Outstanding Youth Talent". And in 2022, he was also in the Fortune"40 Chinese Business Elites under-40" list. He is currently the vice president of the Beijing Branch of MiraclePlus Alumni Association.
Builderx Inc is a technology company focusing on the remote intelligent control of construction machinery, which greatly improves the working environment of construction personnel while achieving safer and more efficient construction operations.
YAN TAN
CO-FOUNDER AND CEO, XBIOMEDr. TAN Yan, co-founder and CEO of Shenzhen Xbiome Biotech Co., Ltd. Xbiome, established in 2017, is China's leading AI-driven clinical-stage microbiome drug development company, dedicating to discover new therapeutics tackling unmet medical needs. In particular, Xbiome develops microbiome therapies such as fecal microbiota transplantation (FMT) and mini-FMT, to alleviate and treat intestinal diseases, among other illnesses. Xbiome builds up an innovative drug discovery platform that combines industry-leading AI technology with advanced bioengineering practices, that speed up the drug development cycle and increase the success rate of drug candidates. Due to his work with Xbiome, Yan was named as one of the "35 Innovators Under 35" by MIT Technology Review, as well as one of the "40 Business Elites under 40" by Fortune China.
Academically, Dr. TAN Yan is a Ph.D. of the Broad Institute of MIT and Harvard in computational biology and bioinformatics. Yan has a wide research area including immunology, microbiology, and computational biology. During his doctoral research, Yan’s work has been published in Immunity, European Journal of Immunology, and other journals. His work using machine learning algorithm predicting immunity based on early-stage gene expression profiles, was recognized as one of the most cited articles in 2014 by European Journal of Immunology. His publications have been cited by Nature, Science, Nature Immunology, Nature Medicine etc. for more than 230 times (google scholar). In Xbiome， Yan has led multiple clinical studies initiated by researchers from top hospitals in China, including Cancer Hospital of Peking University, Shanghai Xinhua Hospital, Southern Medical University, etc.
FANG WANG
EXECUTIVE EDITOR, SHANGHAI, FORTUNE CHINAFang Wang is Executive Editor, Shanghai, of Fortune China. Before joining Fortune in March 2021, she spent 18 years at the Financial Times, holding multiple roles including online news editor (New York City), multimedia producer (London), and senior duty editor of the FT’s Chinese website (Beijing).
Fang graduated from New York University in 2003 with an MA degree in business and economic reporting. She received her BA degree in journalism from Fudan University in Shanghai in 1999. Between 1999 and 2001 she was a technology industry reporter at Shanghai Daily.
SHIQUAN WANG
CO-FOUNDER AND CEO, FLEXIVDr. Shiquan Wang is the Co-founder, CEO and Chief Design Officer of Flexiv, the visiting professor and joint doctoral supervisor in SJTU, a member of SAC/TC 591, and the council member of SIMIA and SRIA. He was selected into the Top Ten X-generation of GMIC 2020 and Shanghai Science & Technology 35 Under 35 list in 2021.
Shiquan graduated from the Biomimetics and Dexterous Manipulation Lab (BDML) and AI Lab (Robotics), Standford University. His research covers a broad robotic types such as quadruped, humanoid, mobile, and underwater. He has published nearly 20 papers in international top journals and conferences and obtained dozens of technological patents in the United States and China.
Shiquan founded Flexiv in 2016, FLEXIV is a global leading general-purpose robotics company, focusing on developing and manufacturing adaptive robots which integrate industrial-grade force control, computer vision and AI technologies. Flexiv provides innovative turnkey solutions and services based on Flexiv robotic systems to customers in multi-industries. Flexiv's adaptive robots have applied for around 200 patents globally and have been implemented in different industries. Recently, the company closed the Series B+ funding and became a unicorn startup.
CARL WU
FOUNDER AND CEO, NEW FRONTIERCarl Wu is the Founder and CEO of New Frontier, a patient-centric healthcare company in China. Since its inception in 2016, Mr. Wu led New Frontier from a start-up to an industry-leading healthcare group covering acute hospitals, outpatient / ambulatory services, rehabilitation hospitals, home health, oncology, health insurance services and health technology, servicing approximately 10 million patients annually.
Mr. Wu is currently the CEO of New Frontier Health / United Family Healthcare. He is also the Executive Chairman and Co-founder of YD Care, Heal Medical, NF GBA Holding, Better Health, Boxful Technology, and HelloToby Technology. Carl is also the Chairman of Care Alliance (the leading post-acute healthcare operator in China).
Prior to founding New Frontier, Mr. Wu was a Managing Director at Blackstone and executed some of Blackstone's most important investments in China. He was a founding member of Blackstone Asia and was instrumental in establishing Blackstone's businesses across China. Mr. Wu worked in Blackstone’s London, Hong Kong, Shanghai, and Beijing offices. Before joining Blackstone, he was an investment banker at UBS in London.
Mr. Wu was acknowledged by Fortune as one of “40 Under 40” global business and political leaders in 2021, and he was acknowledged by Fortune China as one of “40 Under 40” business leaders in 2022.
Mr. Wu holds a Bachelor of Science in Economics from the London School of Economics, where he graduated with First Class Honors.
POLIN HSU
FOUNDER AND CEO, MAGASSISTProfessor Dr.rer.medic. Polin Hsu PhD., the founder & CEO of magAssist, is one of the National Talent Expert and Jiangsu Leading Talents of Technology Innovation. She holds two doctoral degrees, PhD in Electrical Engineering, Cambridge University, UK, and PhD in Medical Engineering, RWTH Aachen University, Germany. She has over 14 years experience in the field, including artificial heart design and system engineering. She is also a professor at Soochow University.
In 2014, Dr. Po-Lin Hsu has become the first Chinese scholar that received Nose International Fellowship Award from the American Society for Artificial Internal Organs (ASAIO). In 2019, she became the first Chinese board member of International Society for Mechanical Circulatory Support (ISMCS) in 30 years history since founding of ISMCS.
In 2017, Dr. Polin Hsu has founded magAssist. She has led magAssist team to complete the development of first product MoyoAssist Extracorporeal Ventricular Assist Device within 3 years. MoyoAssist has entered clinical trials and has saved lives. Meanwhile, magAssist have launched other product lines, including percutaneous ventricular assist device, the new generation ECMO, and Organ Care System, and all of which are in the pre-clinical development stage. magAssist has now become the leading innovators of medical device industry.
ANQI YANG
NEW MEDIA ASSOCIATE EXECUTIVE EDITOR AT FORTUNE CHINAYang Anqi joined FORTUNE China in September 2014 as Senior Editor. From 2013 to 2014, Yang worked as a senior reporter of 《Caijing》Magazine, a famous Chinese business media. From 2009 to 2013, he worked as a senior reporter of 《Global Entrepreneur》Magazine, when he published 10 cover stories in four years. Before that, he also worked as a reporter of 《Beijing Business Today》from from 2008 to 2009.
Yang Anqi graduated from China University of Mining and Technology, and majored in Urban Planning. After graduation, Media Scholarship winner of Renmin University，EMBA Media Scholarship winner, School of Economics and Management, Tsinghua University.
FIONA YU
PARTNER, NORTHERN LIGHT VENTURE CAPITALFiona joined NLVC in 2014, bringing to the firm more than 10 years of experience in the healthcare industry and her strong strategic consulting skillset. Since joining NLVC, Fiona has helped grow the company’s portfolio of healthcare investments to more than 60 companies spanning the biotechnology, diagnostics, digital health, and medical technology spaces. To date, she has been the lead investor on 15 of those investments, and she sits on the boards of five of those organizations. Currently, she works closely with a number of companies, including Cytek Biosciences, Taimei, and Immune-Onc.
Prior to NLVC, Fiona worked at Johnson & Johnson for more seven years, and she also worked in Monitor Deloitte, serving local and multi-national healthcare companies through strategic consulting services.
Fiona holds a BS degree from the Beijing University of Aeronautics and Astronautics and an MBA from Duke University.
FRANKIE YUAN
CEO, GAC CapitalMr. Feng Yuan has been with GAC Group for 15 years and been in charge of multiple important jobs, including market value management, investor relationship, direct financing and investing, and general manager of GAC Capital since 2019. During that time, the market value of GAC has grown from RMB 45 billion to 180 billion. He also invented the concepts of ‘investment empowers mobility’and ‘investment embraces changes‘ and based on the ‘new four modernization in auto industry, he devoted to promote ESG investment in quality developing intelligent networks, new energy and future mobility.
Over the past three years, GAC Capital has invested in over 40 projects and among them,85% of the investments volume focused on Automobile ‘New Four Modernization’. Among the investments in Automobile New Four Modernization, 50% investments are intelligent driving and 50% are new energy battery. During the year of 2020, under Yuan Feng’s leadership, GAC Capital invested more than RMB 1.1 billion in some very famous projects, including CALB（China Lithium Battery Technology Co., Ltd）, Qingtao Development, COSMX, Horizon Robotics, JINGWEI HIRAIN and meanwhile participated in some high tech projects incubating, including Great Bay Tech and Galaxy Auto Tech. Those projects successfully help GAC Group find the leading technology in new energy car production.
HAOQIAN ZHANG
CO-FOUNDER AND CEO, BLUEPHADr. Haoqian Zhang is the co-founder and CEO of Bluepha. He graduated from Peking University with a bachelor’s degree in Biology and a Ph.D. in Integrated Life Sciences (Physics). He has published 20+ research papers in advanced academic journals. He was an instructor of the International Genetically Engineered Machine Competition (iGEM) team of Peking University from 2011 to 2017 and a primary PI of iGEM finalist teams from 2017 to 2021.
He is a member of the Synthetic Biology Committee of Chinese Society of Biotechnology, a chairman of the Joint Innovation Centre for Synthetic Biology Design and Manufacturing of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and a member of the Advisory Committee of the Shenzhen Synthetic Biology Research Major Science and Technology Infrastructure Enterprise Users. He is an editorial board of Synthetic Biology and an invited editorial board of Synthetic and Systems Biotechnology. He is also an invited industry expert at China Merchants Bank Beijing Branch.
Over the years, Dr. Haoqian Zhang has been shortlisted for several awards including the FastCompany list of Most Creative 100 Chinese in Business (2019), the 36Kr "X·36Under36" S-class entrepreneurs (2022), and the Fortune list of Business Elite’s “40 Under 40” in China (2022).
DEREK ZHANG
EXECUTIVE EDITOR AT FORTUNE CHINAZhang joined FORTUNE China in 2009, and was promoted to Executive Editor in 2013. Zhang currently have more than 2.9 million followers on LinkedIn. Before joining FORTUNE China, Zhang was Managing Editor of InformationWeek China. In 2004, he was admitted by Cambridge, Oxford and Carnegie Mellon University and chose to pursue MSc of Computer Science in Oxford. In 2005, he graduated with straight “A”s from Oxford University, gave up an early offer from a sub company of News Corporation in West London and came back home to continue his career in China’s media business.
Zhang has a BA in English & American Studies from Beijing Foreign Studies University and joined China Daily to work as a reporter and editor. In his earlier days, Zhang won the “best story award” from China Daily twice and played a key role in creating the ELT weeklies for the group. Zhang also got the Certificates of "Building a Business" course from Said Business School, Oxford University, and Finance Media EMBA Fellowship Program from PBC School of Finance, Tsinghua University.
LEO ZHENG
FOUNDER AND CEO, LIGHTHOUSE CAPITAL GROUPMr. Leo Zheng founded the Lighthouse Capital Group in 2014, and led it to become a leading boutique investment bank of new economy and industry, covering the fields of financing and mergers and acquisitions, securities underwriting, asset management, etc. In 2020 and 2021, Lighthouse ranked first in the annual announced transaction amount in the field of new economy private equity financing (Qi Ming Technology).
Mr. Leo Zheng graduated from the Accounting Department of Xiamen University with a bachelor's degree and is a director of the UCCA Ullens Art Foundation. Before founding Lighthouse, he had been engaged in corporate financing and mergers and acquisitions for a long time, and successively worked for Ernst&Young, Sinochem International Corporation and Zero2IPO Capital. He has won awards such as "36 Amazing Investors under 36 in 2019 of 36Kr" and "21st Century Business Herald 2020-2021 China's Most Influential Young Investors".
Mr. Leo Zheng has long been concerned about the lifestyle changes brought about by the technological revolution, as well as the corresponding industrial changes and the evolution of enterprise value. He is good at discovering value through research, and have established an effective paradigm for discovering the inflection point of enterprise value, from which he has discovered and helped the top enterprises of the times, such as KUAISHOU (HKEX：01024), Billibili (NASDAQ: BILI), Cargo Lala, Dewu, Yisiwei, Zhihu (NYSE: ZH), etc., and is highly regarded for the value of "capital and strategic partner" embodied in the process of cooperation with entrepreneurs.
JILONG ZHOU
FOUNDER AND CEO, YUNYOU FREIGHTJilong Zhou, founder and CEO of Yunyou Freight, holds bachelor‘s and master's degree in Microelectronics from Peking University. He was previously a vice president at Deutsche Bank, responsible for the investment of tens of billions of yuan. He also served as a consultant of McKinsey & company, and an associate of Investment Banking Department of CICC, where he has participated in the strategy formulation, operation improvement and financing of many enterprises in logistics, technology, finance and other industries.
Yunyou Freight is a smart logistics enterprise invested by Tencent. Its dispatching robot and national highway navigation products are the first at home and abroad, which can reduce costs and increase efficiency for the logistics industry.